Bruker Treasury Stock vs Accounts Payable Analysis

BRKR Stock  USD 58.90  1.83  3.21%   
Bruker financial indicator trend analysis is way more than just evaluating Bruker prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bruker is a good investment. Please check the relationship between Bruker Treasury Stock and its Accounts Payable accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bruker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
To learn how to invest in Bruker Stock, please use our How to Invest in Bruker guide.

Treasury Stock vs Accounts Payable

Treasury Stock vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bruker Treasury Stock account and Accounts Payable. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Bruker's Treasury Stock and Accounts Payable is -0.4. Overlapping area represents the amount of variation of Treasury Stock that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Bruker, assuming nothing else is changed. The correlation between historical values of Bruker's Treasury Stock and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Treasury Stock of Bruker are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Treasury Stock i.e., Bruker's Treasury Stock and Accounts Payable go up and down completely randomly.

Correlation Coefficient

-0.4
Relationship DirectionNegative 
Relationship StrengthVery Weak

Treasury Stock

Accounts Payable

An accounting item on the balance sheet that represents Bruker obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Bruker are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Bruker's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bruker current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bruker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
To learn how to invest in Bruker Stock, please use our How to Invest in Bruker guide.At this time, Bruker's Selling General Administrative is relatively stable compared to the past year. As of 11/26/2024, Sales General And Administrative To Revenue is likely to grow to 0.26, while Tax Provision is likely to drop slightly above 82.4 M.
 2021 2022 2023 2024 (projected)
Gross Profit1.2B1.3B1.5B1.6B
Total Revenue2.4B2.5B3.0B3.1B

Bruker fundamental ratios Correlations

0.970.960.420.850.340.96-0.90.990.960.420.950.960.850.970.530.650.580.950.550.950.140.850.760.260.22
0.970.920.380.750.490.88-0.810.940.870.490.950.940.780.930.50.570.520.950.660.960.130.840.730.230.33
0.960.920.550.910.140.92-0.950.950.940.340.910.980.950.980.530.440.350.950.370.910.010.950.570.260.14
0.420.380.550.51-0.240.38-0.450.420.44-0.390.460.540.60.460.22-0.05-0.070.33-0.10.39-0.060.73-0.040.28-0.2
0.850.750.910.51-0.110.9-0.960.880.910.240.750.860.920.920.40.440.380.790.140.74-0.130.830.490.26-0.12
0.340.490.14-0.24-0.110.160.040.270.130.420.440.27-0.070.190.30.340.410.350.930.460.480.10.560.070.53
0.960.880.920.380.90.16-0.940.980.990.420.840.90.840.960.430.720.660.880.390.840.060.780.750.260.17
-0.9-0.81-0.95-0.45-0.960.04-0.94-0.92-0.94-0.35-0.79-0.89-0.93-0.96-0.45-0.5-0.42-0.87-0.23-0.790.08-0.83-0.58-0.34-0.08
0.990.940.950.420.880.270.98-0.920.980.390.930.950.860.970.540.670.610.930.490.930.140.840.760.260.17
0.960.870.940.440.910.130.99-0.940.980.350.870.920.870.950.490.690.610.890.360.860.070.820.720.250.09
0.420.490.34-0.390.240.420.42-0.350.390.350.290.340.230.43-0.190.380.380.510.50.38-0.360.170.53-0.020.48
0.950.950.910.460.750.440.84-0.790.930.870.290.950.820.880.680.50.440.930.610.990.280.870.680.240.15
0.960.940.980.540.860.270.9-0.890.950.920.340.950.910.950.540.460.380.940.470.960.080.950.610.260.15
0.850.780.950.60.92-0.070.84-0.930.860.870.230.820.910.910.510.260.180.870.170.8-0.10.940.390.3-0.05
0.970.930.980.460.920.190.96-0.960.970.950.430.880.950.910.460.540.490.940.420.88-0.010.880.650.30.2
0.530.50.530.220.40.30.43-0.450.540.49-0.190.680.540.510.460.210.120.570.40.630.740.50.360.230.11
0.650.570.44-0.050.440.340.72-0.50.670.690.380.50.460.260.540.210.960.470.480.510.280.210.90.060.26
0.580.520.35-0.070.380.410.66-0.420.610.610.380.440.380.180.490.120.960.390.520.430.240.140.870.090.21
0.950.950.950.330.790.350.88-0.870.930.890.510.930.940.870.940.570.470.390.550.950.080.860.660.290.26
0.550.660.37-0.10.140.930.39-0.230.490.360.50.610.470.170.420.40.480.520.550.630.420.30.760.160.59
0.950.960.910.390.740.460.84-0.790.930.860.380.990.960.80.880.630.510.430.950.630.230.860.690.240.21
0.140.130.01-0.06-0.130.480.060.080.140.07-0.360.280.08-0.1-0.010.740.280.240.080.420.23-0.030.290.110.28
0.850.840.950.730.830.10.78-0.830.840.820.170.870.950.940.880.50.210.140.860.30.86-0.030.380.290.04
0.760.730.57-0.040.490.560.75-0.580.760.720.530.680.610.390.650.360.90.870.660.760.690.290.380.140.38
0.260.230.260.280.260.070.26-0.340.260.25-0.020.240.260.30.30.230.060.090.290.160.240.110.290.14-0.01
0.220.330.14-0.2-0.120.530.17-0.080.170.090.480.150.15-0.050.20.110.260.210.260.590.210.280.040.38-0.01
Click cells to compare fundamentals

Bruker Account Relationship Matchups

Bruker fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets2.8B3.0B3.7B3.6B4.2B4.5B
Total Stockholder Equity917.1M975.6M1.1B1.1B1.4B1.4B
Non Current Assets Total975.2M1.1B1.2B1.5B2.1B2.2B
Non Currrent Assets Other16.8M39.6M70.8M(99.8M)175.7M184.5M
Other Assets77.3M180M160.9M208.9M240.2M252.2M
Common Stock Shares Outstanding156.6M154.6M152.9M149.4M147.2M143.8M
Liabilities And Stockholders Equity2.8B3.0B3.7B3.6B4.2B4.5B
Non Current Liabilities Total1.2B1.3B1.6B1.6B1.6B1.7B
Other Stockholder Equity(333.8M)(450.7M)(582.5M)(828.7M)(954.3M)(906.6M)
Total Liab1.9B2.1B2.6B2.5B2.8B3.0B
Short Long Term Debt Total860.3M891.5M1.3B1.2B1.4B1.4B
Other Current Liab388.8M210.1M234.4M596.8M316.2M237.4M
Total Current Liabilities645.6M793.6M938.5M913.8M1.2B1.3B
Property Plant And Equipment Net371.7M462.9M406.1M487M691.4M726.0M
Net Debt182M209.7M266M573.7M891.3M935.9M
Retained Earnings1.3B1.4B1.7B1.9B2.3B2.4B
Accounts Payable118.4M134.6M147.4M178.4M202.7M212.8M
Cash678.3M681.8M1.1B645.5M488.3M311.3M
Cash And Short Term Investments684.9M731.8M1.2B645.5M488.3M358.2M
Net Receivables362.2M335.3M416.9M595.3M621.8M652.9M
Inventory577.2M692.3M710.1M803.7M968.3M1.0B
Other Current Assets172M165.6M176.6M72.3M85.8M108.0M
Property Plant And Equipment Gross371.7M462.9M406.1M487M1.2B1.3B
Total Current Assets1.8B1.9B2.5B2.1B2.2B1.1B
Accumulated Other Comprehensive Income(25.5M)3.7M(8.2M)14.8M6M5.7M
Short Term Debt500K23.5M130.3M35.1M144.5M151.7M
Intangible Assets603.5M229.1M211.8M270.9M330.5M196.5M
Other Liab311M389.4M404.9M318.2M365.9M384.2M
Long Term Debt812.8M842.3M1.2B1.2B1.2B1.2B
Short Term Investments0.06.6M50M100M12M11.4M
Property Plant Equipment306.1M395.5M406.1M487M560.1M588.1M
Current Deferred Revenue137.9M189.2M197.5M225.7M400M420M
Treasury Stock(543.8M)(667M)(820.3M)(1.1B)(976.5M)(927.7M)
Good Will293M320.4M339.5M457.6M582.6M611.7M
Net Tangible Assets491.5M509.6M312.5M1.2B1.4B1.5B
Noncontrolling Interest In Consolidated Entity10.3M13.1M14.1M11.9M13.7M8.2M
Retained Earnings Total Equity1.3B1.4B1.7B1.9B2.2B2.3B
Long Term Debt Total812.8M842.3M1.2B1.2B1.4B1.4B

Pair Trading with Bruker

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bruker position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bruker will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bruker Stock

  0.87A Agilent TechnologiesPairCorr
  0.89ME 23Andme HoldingPairCorr
  0.61VALN Valneva SE ADRPairCorr

Moving against Bruker Stock

  0.8EXEL ExelixisPairCorr
  0.75BMY Bristol Myers Squibb Sell-off TrendPairCorr
  0.56EWTX Edgewise TherapeuticsPairCorr
  0.45KTTAW Pasithea TherapeuticsPairCorr
The ability to find closely correlated positions to Bruker could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bruker when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bruker - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bruker to buy it.
The correlation of Bruker is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bruker moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bruker moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bruker can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Bruker Stock Analysis

When running Bruker's price analysis, check to measure Bruker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bruker is operating at the current time. Most of Bruker's value examination focuses on studying past and present price action to predict the probability of Bruker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bruker's price. Additionally, you may evaluate how the addition of Bruker to your portfolios can decrease your overall portfolio volatility.